Insights

GSK Consumer Healthcare Ltd

April 23, 2016 . Equities Desk

GlaxoSmithKline Consumer Healthcare (GSKCH) is an associate of GlaxoSmithKline plc UK, which holds 72.46% stake in the company. It is India’s dominant player in health food drink (HFD) category with 67.3% market share. While Horlicks leads the market, Boost is among the top three health food drink brands.

Valuation and view

GSKCH is better placed than peers given its strong pricing power, leadership position and distribution reach in the core HFD portfolio. We expect revenue and PAT to grow at a CAGR of 9.8% and 15.8% over FY15-FY18E. Further, we rate the stock as ‘BUY’ assigning a forward P/E of 31.5x arriving at a target price of Rs. 6,788 which implies potential upside of ~12% for next 12 months.

Research Report GSK Consumer Healthcare Ltd

Investments in equity shares, debentures, etc., are not obligations of, or guaranteed by Wealth India Financial Services Pvt. Ltd., and are subject to investment risks. Click here to read our full disclaimer.

Get FundsIndia’s articles delivered straight to your inbox!

Enter your email address to get:

  • Mutual fund recommendations from experts
  • Buy, hold or sell calls for stocks
  • Investment tips and tricks
  • All the latest news from Fundsindia.com

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.